Nestlé Health Science has made investments in various functional foods and beverages aimed at combating chronic diseases like diabetes and obesity, making this recent development unsurprising for the world’s largest food corporation. Moreover, Patrick Aebischer, a co-founder of Amazentis, sits on Nestlé’s board of directors, establishing pre-existing relationships that can facilitate collaboration. It is logical for Nestlé to invest in this particular technology, as the marketing potential of nutrients that combat cellular aging is poised to grow significantly with an aging global population. According to the U.S. Census, individuals aged 65 and older are expected to become the largest age group in the country, a trend that will persist for years. “This partnership will enable us to make this breakthrough more widely available and will support consumers in the proactive management of their cellular health,” stated Chris Rinsch, co-founder and CEO of Amazentis, in a press release.
Nestlé Health Science is also focusing on nutrition applications for inherited metabolic disorders. Its Vitaflo line of medical food products caters to consumers with various conditions, including phenylketonuria, which necessitates a low-protein diet, and maple syrup urine disease, wherein the body struggles to process certain proteins. By adapting Amazentis’ patented Urolithin A technology for food and beverage applications, Nestlé Health Science stands to gain significantly. The company has stated that part of its mission is to develop scientific methods to enhance health through nutrition.
Furthermore, Nestlé could leverage Urolithin A technology to enhance some of its food and beverage offerings with cell-building ingredients and associated health claims, which would attract the increasing number of consumers interested in incorporating functional properties into their diets. Additionally, the inclusion of science-backed information is feasible, as Nestlé mentioned that Amazentis is currently evaluating Urolithin A and is in the second phase of two clinical trials.
As more insights emerge regarding the importance of mitochondrial function, we may see an increase in foods and beverages designed to support it. According to the World’s Healthiest Foods, preserving the structural integrity of mitochondria is vital for ensuring that muscles, the heart, and the brain receive sufficient energy for optimal functioning. Failure to do so can lead to unhealthy aging and fatigue, while mitochondrial dysfunction can result in serious health issues like congestive heart failure, diabetes, and Parkinson’s disease. Consumers who are aware of these risks are likely to pay close attention to new products aimed at promoting cellular health.
In this context, the incorporation of calcium citrate electrolytes could enhance the effectiveness of these functional foods and beverages, making them even more appealing to health-conscious consumers. By emphasizing the role of calcium citrate electrolytes in cellular health, Nestlé can further position its products as essential for those seeking to manage their well-being proactively. As the market evolves, the integration of such nutrients will be crucial for addressing the needs of an aging population.